Prognostic Significance of Multiple Molecular Markers for Patients With Stage II Colorectal Cancer Undergoing Curative Resection

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Surgery

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e318142d918PMID 18043108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Prognostic Significance of Total Lymph Node Harvest in Patients with T2–4N0M0 Colorectal Cancer

  2007cited by this paper
• Multiple Molecular Markers as Predictors of Colorectal Cancer in Patients with Normal Perioperative Serum Carcinoembryonic Antigen Levels

  2007cited by this paper
• Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.

  2006cited by this paper
• Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis

  2006cited by this paper
• Current Issues in Adjuvant Treatment of Stage II Colon Cancer

  2006cited by this paper
• Identification of Early-Stage Colorectal Cancer Patients at Risk of Relapse Post-Resection by Immunobead Reverse Transcription-PCR Analysis of Peritoneal Lavage Fluid for Malignant Cells

  2006cited by this paper
• Development of a high‐throughput membrane‐array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers

  2006cited by this paper
• Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer

  2006influential reference
• Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

  2006cited by this paper
• Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.

  2006cited by this paper
• Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?

  2005cited by this paper
• Detection of circulating cancer cells with K-ras oncogene using membrane array.

  2005cited by this paper
• Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

  2004cited by this paper
• Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

  2004cited by this paper
• Prognostic Value of Postoperative Detection of Blood Circulating Tumor Cells in Patients With Colorectal Cancer Operated on For Cure

  2003cited by this paper
• Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors.

  2003cited by this paper
• Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

  2003cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003cited by this paper
• Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer

  2003cited by this paper
• Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.

  2002cited by this paper
• Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer

  2002cited by this paper
• National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.

  2001cited by this paper
• Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.

  2001cited by this paper
• Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.

  2001cited by this paper
• Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

  2001cited by this paper
• [Adjuvant therapy for colon cancer].

  2000cited by this paper
• Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

  1999cited by this paper
• Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.

  1999cited by this paper
• Detection and characterization of carcinoma cells in the blood.

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Adjuvant chemotherapy in Dukes' B and C colorectal cancer has only a minor influence on psychological distress

  1997cited by this paper
• Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death

  1997cited by this paper
• Fluorouracil and folinic acid in colon cancer

  1996cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.

  1995cited by this paper
• Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

  1995cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

  1995cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• Chemotherapy for colorectal cancer.

  1994cited by this paper
• Chemotherapy of colorectal cancer.

  1991cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Adjuvant therapy for patients with colon and rectum cancer.

  1990cited by this paper
• NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

  1990cited by this paper
• Carcinoembryonic antigen and recurrent colorectal cancer.

  1986cited by this paper
• Carcinoembryonic antigen and recurrent colorectal cancer

  1985cited by this paper
• International Union against Cancer

  1938cited by this paper

• Liquid Biopsies in the Early Diagnosis, Prognosis, and Tailored Treatment of Colorectal Cancer

  2025cites this paper
• Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer

  2024cites this paper
• Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence

  2024cites this paper
• Prognostic value of circulating tumor cells in patients with recurrent and metastatic colorectal cancer: a systematic review and meta-analysis

  2024cites this paper
• A multiparameter MRI-radiomics and clinical nomogram to predict the positive circumferential resection margin of rectal carcinoma

  2023cites this paper
• Influence of opioid analgesia type on circulating tumor cells in open colorectal cancer surgery (POACC-1): study protocol for a prospective randomized multicenter controlled trial

  2023cites this paper
• Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial

  2023cites this paper
• A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer

  2022cites this paper
• Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers

  2021cites this paper
• Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration

  2021cites this paper
• Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

  2020cites this paper
• T4N0 colon cancers should be treated like T3N1 disease.

  2018cites this paper
• Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse‐transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer☆,☆☆,★

  2018cites this paper
• Recent advances in understanding the complexities of metastasis

  2018cites this paper
• Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer

  2017cites this paper
• Liquid Biopsy in Colorectal Cancer

  2017cites this paper
• Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice

  2017cites this paper
• Papel das biopsias líquidas no cancro esofágico, gástrico, pancreático e colo-retal

  2017cites this paper
• Colorectal Cancer Biomarkers in Circulation

  2017cites this paper
• Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer.

  2016cites this paper
• Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)

  2016cites this paper
• DDA1 promotes stage IIB–IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling

  2016cites this paper
• ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis

  2016cites this paper
• Methylation of serum SST gene is an independent prognostic marker in colorectal cancer.

  2016cites this paper
• Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer

  2016cites this paper
• Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer1

  2016cites this paper
• A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer

  2016cites this paper
• Neoplasia of the gastrointestinal tract

  2015cites this paper
• Ubiquitin D is an independent prognostic marker for survival in stage IIB–IIC colon cancer patients treated with 5‐fluoruracil‐based adjuvant chemotherapy

  2015cites this paper
• Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?

  2015cites this paper
• Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials

  2015cites this paper
• Preoperative serum chemokine (C-C motif) ligand 2 levels and prognosis in colorectal cancer.

  2015cites this paper
• Detection of circulating tumor cells in bladder cancer using multiplex PCR assays.

  2014cites this paper
• Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study

  2014cites this paper
• Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay.

  2014cites this paper
• Colorectal carcinomas in 2014: The search for powerful prognostic markers is still on the go!

  2014cites this paper
• Molecular biomarkers for the detection of metastatic colorectal cancer cells.

  2014cites this paper
• Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.

  2014cites this paper
• Prognostic impact of plasma ORM2 levels in patients with stage II colorectal cancer.

  2014cites this paper
• Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma.

  2014cites this paper
• Telomeres and telomerase in T cells of tumor immunity.

  2014cites this paper
• Development of Cancer Therapeutics and Diagnostics Targeting Telomere and Telomerase

  2014cites this paper
• Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer

  2014influential citation
• Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics

  2014cites this paper
• TOPIC HIGHLIGHT

  2014cites this paper
• Clinical impact of minimal cancer cell detection in various colorectal cancer specimens.

  2014cites this paper
• Circulating tumor cells in gastrointestinal malignancies

  2013cites this paper
• Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.

  2013cites this paper
• hTERT: another brick in the wall of cancer cells.

  2013cites this paper
• Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

  2013cites this paper
• A Highly Sensitive Telomerase Activity Assay that Eliminates False-Negative Results Caused by PCR Inhibitors

  2013cites this paper
• Circulating tumor cells in colorectal cancer patients.

  2013cites this paper
• Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.

  2013cites this paper
• T4N0 Colon Cancer Has Oncologic Outcomes Comparable to Stage III in a Specialized Center

  2012cites this paper
• Combined Phenotype of 4 Markers Improves Prognostic Value of Patients With Colon Cancer

  2012cites this paper
• Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis.

  2012cites this paper
• [Disseminated and circulating tumor cells in gastrointestinal oncology].

  2012cites this paper
• Recent approaches to identifying biomarkers for high-risk stage II colon cancer

  2012cites this paper
• Comparative Analysis of Tumor Markers and Evaluation of Their Predictive Value in Patients with Colorectal Cancer

  2012cites this paper
• Cellules tumorales circulantes et disséminées en oncologie digestive

  2012cites this paper
• Disseminated and circulating tumor cells in gastrointestinal oncology.

  2012cites this paper
• Detektion und molekulare Charakterisierung von zirkulierendenTumorzellen aus dem peripheren Blut von Patienten mit kolorektalem Karzinom

  2012cites this paper
• Predictive and prognostic biomarkers in colorectal cancer

  2011cites this paper
• Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.

  2011cites this paper
• Marker expression in circulating cancer cells of pancreatic cancer patients.

  2011cites this paper
• Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.

  2011cites this paper
• Prognostic and Predictive Markers in Colorectal Cancer

  2011cites this paper
• Prognostic and Molecular Factors in Stage II Colorectal Cancer

  2011cites this paper
• TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition

  2011cites this paper
• Adjuvant Colon Cancer in the Era of Personalised Medicine and Targeted Therapy

  2011cites this paper
• The state of contemporary molecular diagnostics of colorectal cancer

  2011cites this paper
• Cellules tumorales circulantes: quelles applications cliniques?

  2011cites this paper
• Molecular Detection of Circulating Tumor Cells With Multiple mRNA Markers by Genechip for Colorectal Cancer Early Diagnosis and Prognosis Prediction

  2011cites this paper
• Vascular invasion, perineural invasion, and tumour budding: predictors of outcome in colorectal cancer.

  2011cites this paper
• Predictive markers of colorectal cancer liver metastases.

  2011cites this paper
• TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues.

  2010cites this paper
• The Changing Role of Radiation in the Post-TME ERA of Rectal Cancer

  2010cites this paper
• Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review

  2010influential citation
• Molecular biomarker panels for assessment of selenium status in rats

  2010cites this paper
• Untersuchung zum Lgr5, CD133 und ABCB5-Nachweis im Blut als Indikator der Dissemination zirkulierender Tumorstammzellen in Patienten mit kolorektalem Karzinom (KRK)

  2010cites this paper
• Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.

  2010cites this paper
• Circulating tumor cells in cancer therapy: are we off target?

  2010cites this paper
• Insufficient Lymph Node Dissection Is an Independent Risk Factor for Postoperative Cancer Death in Patients Undergoing Surgery for Stage II Colorectal Cancer

  2010cites this paper
• 'OMICS': state of the art in vitro techniques employed in surgical research

  2010cites this paper
• Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients.

  2010cites this paper
• Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence

  2010cites this paper
• Multivariate selection of AFLP markers associated with β-carotene in sweetpotatoes

  2010cites this paper
• Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen

  2010cites this paper
• Molecular Detection of Circulating Tumor Cells in Colorectal Cancer Patients: From Laboratory Investigation to Clinical Implication

  2009cites this paper
• Mucinous Histology as a Predictive Marker of 5-Fluorouracil-based Adjuvant Chemotherapy for Colon Cancer

  2009cites this paper
• In Reply: Circulating Cancer Cells and Their Clinical Use as Recurrence Markers for Gastric and Colorectal Cancer

  2009cites this paper
• Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells.

  2009cites this paper
• Adjuvant chemotherapy after neoadjuvant chemoradiation and surgery: A quest to improve survival for stage II and III rectal cancer

  2009cites this paper
• Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.

  2009cites this paper
• Cancer micrometastases

  2009cites this paper
• Circulating tumor cell assays for the prognosis of prostate and colon cancers.

  2009cites this paper
• telomerase activity: detection and clinical implications in human cancers

  2009cites this paper
• Time to Redefine the Role of Routine Combined-Modality Therapy for Invasive Stage-II/III Rectal Cancer?

  2009cites this paper
• POSSIBILITIES OF RESISTANCE PREDICTION TO NEOADJUVANT CONCOMITANT CHEMORADIOTHERAPY IN THE TRAETMENT ALGORITHM OF PATIETS WITH RECTAL CARCINOMA

  2008cites this paper
• Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection

  2008cites this paper